In the present study, we showed that deficiency of NLRP3, ASC, and IL-1β attenuates inflammatory and fibrotic responses after MGO treatment, resulting in less peritoneal fibrosis in a murine model of PD-related peritoneal fibrosis and EPS. This evidence concerns the gene NLRP3 and Peritoneal Fibrosis.